Effect of intracoronary dipyridamole on abrupt vessel closure and secondary end points in the intention to treat analysis
| Dipyridamole n=550 | Conventional n=544 |
Odds ratio (95% CI) | p Value | |
| All patients | ||||
| Abrupt vessel closure | 15 (2.6%) | 34 (5.9%) | 0.44 (0.24 to 0.80) | 0.005 |
| Acute myocardial infarction | 8 (1.4%) | 18 (3.2%) | 0.44 (0.19 to 0.99) | 0.05 |
| CABG | 0 | 3 (0.6%) | ||
| Exitus | 1 (0.2%) | 2 (0.4%) | ||
| Stable angina | ||||
| Abrupt vessel closure | 10 (2.0%) | 21 (4.4%) | 0.47 (0.22 to 0.98) | 0.05 |
| Acute myocardial infarction | 6 (1.2%) | 12 (2.5%) | 0.49 (0.19 to 1.30) | 0.16 |
| CABG | 0 | 2 (0.4%) | ||
| Exitus | 1 (0.2%) | 1 (0.2%) | ||
| Acute coronary syndrome | ||||
| Abrupt vessel closure | 5 (5.9%) | 13 (14.6%) | 0.41 (0.15 to 1.09) | 0.06 |
| Acute myocardial infarction | 2 (2.4%) | 6 (6.7%) | 0.35 (0.07 to 1.70) | 0.28 |
| CABG | 0 | 1 (1.3%) | ||
| Exitus | 0 | 1 (1.3%) | ||